Excess soluble CD40L contributes to blood brain barrier permeability in vivo: implications for HIV-associated neurocognitive disorders.
Despite the use of anti-retroviral therapies, a majority of HIV-infected individuals still develop HIV-Associated Neurocognitive Disorders (HAND), indicating that host inflammatory mediators, in addition to viral proteins, may be contributing to these disorders. Consistently, we have previously show...
Main Authors: | Donna C Davidson, Michael P Hirschman, Anita Sun, Meera V Singh, Karl Kasischke, Sanjay B Maggirwar |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3520914?pdf=render |
Similar Items
-
Valproic acid inhibits the release of soluble CD40L induced by non-nucleoside reverse transcriptase inhibitors in human immunodeficiency virus infected individuals.
by: Donna C Davidson, et al.
Published: (2013-01-01) -
Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.
by: Sophie Doublier, et al.
Published: (2017-01-01) -
YKL-40 Correlates with Soluble CD 40 Ligand in Old Myocardial Infarction with Hypertension
by: Diah Kumalasari, et al.
Published: (2012-04-01) -
Association of soluble CD40 levels with ‐1 C > T CD40 polymorphism and chronic kidney disease in systemic lupus erythematosus
by: Raziel Tapia‐Llanos, et al.
Published: (2019-12-01) -
Plasma soluble CD40 concentration in patients with delayed pressure urticaria
by: T Jasinska, et al.
Published: (2015-08-01)